Cathepsin B Protein

Migration, Crosslink

📖

Cathepsin B Protein

active

wiki page Created: 2026-04-02T07:19:12 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-cathepsin-b

📖 Wiki Page

protein1112 wordssynced 2026-04-02

Cathepsin B Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Cathepsin B Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Cathepsin B</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CTSB</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P07846</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>38 kDa (339 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomes, endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Cysteine cathepsin family (papain-like)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Cathepsin B inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">CA-074Me</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">None approved</td>
<td>—</td>
</tr>
<tr>
<td class="label">Drug/Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">CA-074Me</td>
<td>Selective inhibitor</td>
</tr>
<tr>
<td class="label">CA-030</td>
<td>Reversible inhibitor</td>
</tr>
<tr>
<td class="label">AAV-CTSB</td>
<td>Gene therapy</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Increase activity</td>
</tr>
</table>

...

Cathepsin B Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Cathepsin B Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Cathepsin B</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CTSB</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P07846</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>38 kDa (339 amino acids)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Lysosomes, endosomes</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Cysteine cathepsin family (papain-like)</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Cathepsin B inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">CA-074Me</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">None approved</td>
<td>—</td>
</tr>
<tr>
<td class="label">Drug/Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">CA-074Me</td>
<td>Selective inhibitor</td>
</tr>
<tr>
<td class="label">CA-030</td>
<td>Reversible inhibitor</td>
</tr>
<tr>
<td class="label">AAV-CTSB</td>
<td>Gene therapy</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Increase activity</td>
</tr>
</table>

Cathepsin B Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

Cathepsin B is a lysosomal cysteine protease involved in protein degradation within lysosomes. It plays important roles in protein turnover, autophagy, and extracellular matrix remodeling. Cathepsin B has been studied extensively in Alzheimer's disease for its ability to degrade [amyloid-beta](/proteins/amyloid-beta) and its role in inflammatory responses. [@muellersteiner2006]

Protein Information

Structure

Signal peptide: Targets to secretory pathway

Propeptide (25 aa): Inhibits activity until processing

Mature enzyme: Catalytic domain with occluding loop

Dipeptide removal: Final activation step

Normal Function

Lysosomal protease: Degrades proteins in lysosomes
Protein turnover: Cellular protein homeostasis
[Autophagy](/entities/autophagy): Role in autophagic-lysosomal degradation
ECM remodeling: Degrades extracellular matrix proteins
Antigen processing: MHC class II loading

Role in Disease

Alzheimer's Disease

Aβ degradation: Cathepsin B can degrade [amyloid-beta](/proteins/amyloid-beta)
Dual role: May also generate Aβ fragments
Therapeutic potential: Enhancing cathepsin B activity
Expression changes: Increased in AD brain

Parkinson's Disease

Lysosomal dysfunction: Implicated in PD pathogenesis
Alpha-synuclein degradation: May degrade α-syn
GBA associations: Interactions with GBA1

Other Diseases

Cancer: Overexpression promotes tumor invasion
Arthritis: Role in cartilage degradation
Pancreatitis: Involved in tissue damage

Therapeutic Targeting

Key Publications

Hook VY, et al. (2008). Cathepsin B is a new drug target. Drug News Perspect. 21(9):470-6. https://doi.org/10.1358/dnp.2008.21.9.1272060

Mueller-Steiner S, et al. (2006). Antiamyloidogenic functions of cathepsin B. Neuron. 51(6):703-14. https://doi.org/10.1016/j.neuron.2006.07.027

Wolfe DM, et al. (2010). Autophagy failure in Alzheimer's disease. Exp Neurol. 226(2):245-53. https://doi.org/10.1016/j.expneurol.2010.08.001

Expression Pattern

Cathepsin B is expressed in various cell types throughout the brain:

[Neurons](/entities/neurons): Moderate expression in cortical and hippocampal neurons
[Microglia](/entities/microglia): High expression in activated [microglia](/cell-types/microglia), especially in disease states
[Astrocytes](/entities/astrocytes): Variable expression, increased in reactive astrocytes
Oligodendrocytes: Lower baseline expression

In the healthy brain, cathepsin B localizes primarily to lysosomes in the soma and proximal dendrites. During neurodegeneration, its subcellular distribution changes, with increased expression in dystrophic neurites surrounding amyloid plaques in AD brain.

Molecular Mechanisms

Amyloid-Beta Metabolism

Cathepsin B exhibits a complex relationship with amyloid-beta (Aβ):

Degradation: Can cleave and degrade Aβ40 and Aβ42 peptides

Generation: May generate Aβ fragments through non-canonical processing

Secretion: Released in [exosomes](/entities/exosomes) under certain conditions

Inflammation: Activates inflammatory responses through [NLRP3](/proteins/nlrp3) inflammasome

Autophagy-Lysosomal Pathway

Cathepsin B is crucial for autophagic degradation:

Maturation: Required for proper autophagosome-lysosome fusion
Activity: Optimal at acidic pH (4.5-5.5) in lysosomes
Dysfunction: Cathepsin B activity declines with aging
Inhibition: CA-074Me and other inhibitors block autophagic flux

Cell Death Pathways

Cathepsin B can initiate both apoptotic and necrotic cell death:

Extracellular release: Escapes lysosomes during cellular stress
Caspase activation: Can activate caspase-8 and caspase-3
Mitochondrial dysfunction: Induces cytochrome c release
[Necroptosis](/mechanisms/necroptosis): Associated with necroptotic cell death

Biomarker Potential

Cathepsin B has been investigated as a biomarker:

CSF levels: Elevated in AD, PD, and MCI patients
[Blood-brain barrier](/entities/blood-brain-barrier): Peripheral levels may reflect CNS pathology
Exosome markers: Detectable in neuron-derived exosomes
Therapeutic monitoring: Could track lysosomal modulation efficacy

Drug Development

Current therapeutic strategies targeting cathepsin B:

Research Directions

Key areas of ongoing research:

Target validation: Confirm cathepsin B as therapeutic target

Blood-brain barrier: Develop CNS-penetrant inhibitors

Selective modulation: Achieve substrate-specific activation

Combination therapy: Pair with Aβ immunization or clearance

Disease Associations

Alzheimer's Disease

Cathepsin B upregulation in AD brains
Enhanced amyloid-beta degradation by cathepsin B
Possible therapeutic target
Increased activity in [microglia](/cell-types/microglia-neuroinflammation) surrounding plaques
Contradictory reports on net effect

Parkinson's Disease

Elevated cathepsin B in PD substantia nigra
Role in [alpha-synuclein](/proteins/alpha-synuclein) degradation
May contribute to Lewy body formation
Lysosomal dysfunction affects activity

Amyotrophic Lateral Sclerosis

Cathepsin B in motor neuron disease
Altered lysosomal enzyme profiles
Biomarker potential in CSF
Correlation with disease progression

Cancer

Overexpression in various cancers
Role in tumor invasion and metastasis
Prognostic biomarker
Therapeutic target

Therapeutic Approaches

Cathepsin B Inhibitors

CA-074 - selective cathepsin B inhibitor
E-64 - broad cysteine protease inhibitor
ANT201 - nitrile-based inhibitor
Brain-penetrant versions in development

Drug Repurposing

Disulfiram - cathepsin B inhibition
Cystatin C enhancement
Lysosomal function enhancement

Gene Therapy

AAV delivery of cathepsin B
siRNA approaches
CRISPR editing

Research Directions

Understanding cathepsin B substrate specificity
Developing selective brain-penetrant inhibitors
Biomarker development for neurodegenerative diseases
Role in specific cell types

External Links

[UniProt: P53611](https://www.uniprot.org/uniprot/P53611)
[NCBI Gene: 1508](https://www.ncbi.nlm.nih.gov/gene/1508)
[Wikipedia: Cathepsin B](https://en.wikipedia.org/wiki/Cathepsin_B)
[Human Protein Atlas](https://www.proteinatlas.org/ENSG00000100129-CTSB)

Background

The study of Cathepsin B Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Hook V, Yoon M, Mosier C, et al, Cathepsin B and D in CSF: biomarkers for neurodegenerative disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32847978/)

[Mueller-Steiner S, Zhou Y, Arai H, et al, Antiamyloidogenic and neuroprotective functions of cathepsin B (2006)](https://pubmed.ncbi.nlm.nih.gov/16982417/)

[Wang C, Tammi M, Tammi R, et al, Distribution of cathepsins B, D in human brain (1992)](https://pubmed.ncbi.nlm.nih.gov/1382019/)

[Cataldo AM, Paskevich PA, Kominami E, Nixon RA, Lysosomal system in Alzheimer disease (1991)](https://pubmed.ncbi.nlm.nih.gov/1763010/)

[Wendt W, Zhu X, Deng HB, et al, Cathepsin D and B in brain (2004)](https://pubmed.ncbi.nlm.nih.gov/15554152/)

📖 View canonical wiki page →

Related Entities

CATHEPSINB

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-cathepsin-b
kg_node_id	CATHEPSINB
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-77eca71acb43
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-cathepsin-b'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

182

Outgoing

186

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Cathepsin B Protein

Cathepsin B Protein

Introduction

Cathepsin B Protein

Introduction

Overview

Protein Information

Structure

Normal Function

Role in Disease

Alzheimer's Disease

Parkinson's Disease

Other Diseases

Therapeutic Targeting

Key Publications

Expression Pattern

Molecular Mechanisms

Amyloid-Beta Metabolism

Autophagy-Lysosomal Pathway

Cell Death Pathways

Biomarker Potential

Drug Development

Research Directions

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Cancer

Therapeutic Approaches

Cathepsin B Inhibitors

Drug Repurposing

Gene Therapy

Research Directions

See Also

External Links

Background

References

💬 Discussion